Indolent Prognostic Index (iATL-PI) of Katsuya et al for Chronic or Smoldering Adult T-Cell Leukemia/Lymphoma (ATL)

Description

Katsuya et al reported a prognostic index for patients with chronic or smoldering Adult T-cell leukemia/lymohoma. This can help to identify a patient who may benefit from more aggressive management. The authors are from multiple institutions in Japan.

Patient selection: chronic or smoldering adult T-cell leukemia/lymphoma

Parameter:

(1) soluble interleukin-2 receptor (sIL-2R) in U/mL

indolent ATL-PI =

= (1.51 * (LOG10(sIL-2R)))

sIL-2R in U/mL	Risk Group	Median Survival Time
< 1000	low	> 10 years
1000 to 6000	intermediate	5.5 years
> 6000	high	1.5 years

sIL-2R in U/mL	indolent ATL-PI
< 1000	< 4.53
1000 to 6000	4.53 to 5.705
> 6000	> 5.705

Performance:

• The assay for sIL-2R needs to be accurate and precise.

To read more or access our algorithms and calculators, please log in or register.

Indolent Prognostic Index (iATL-PI) of Katsuya et al for Chronic or Smoldering Adult T-Cell Leukemia/Lymphoma (ATL)

Description

Specialty